Skip to content
PeptidePlotter logo PeptidePlotter
Search (no-JS fallback)

Peptides

FOXO4-DRI

Also called FOXO4-DRI · DRI-FOXO4

FOXO4-DRI is explored for healthier aging by removing some damaged cells that stop dividing but remain in tissues. The hoped-for benefits are better physical function and organ health. The famous rejuvenation results are from mice; they do not establish that a person will look younger, live longer or benefit from a short “cell-clearing” cycle.

Open the plotter Sources

Dosage & duration

Human amount, timing and cycle

Research status

Published example · product-specific
Dose
No established human dose
How often
No validated human frequency
How long
No established longevity cycle

Reviewed online protocols extrapolate from mouse studies or isolated reports. Those calculations are not a human safety or dose-finding study.

Sources: 1

A low amount or a long break does not by itself establish safe cell clearance. Do not use a plotted curve to choose a senolytic cycle.

More quick facts
Main goal
Healthier aging
Sources : 1
Senolytic meaning
Removing some senescent cells
Sources : 1
Human cycle
Not established
Sources : 1

Healthy-aging interest

More healthy, active years

  • Staying capable

    The hope is lasting mobility and physical function as people age.

  • Health that holds up

    Improved organ health would matter more than simply feeling different after a course.

  • A meaningful change

    A lower biological-age score alone does not establish extra healthy years.

The cited FOXO4-DRI results come from cells and mice; they do not establish rejuvenation or a safe course in people. Sources and context
In this guide

Why do longevity readers care?

The attraction is tackling one proposed contributor to aging instead of chasing a single symptom. In the original study, researchers saw changes in physical and tissue measures in mice. That creates a reason to study the idea, not a predictable rejuvenation package for people.

Are “zombie cells” always useless?

The nickname oversimplifies a complex process. Senescence and cell removal are not the same as cleaning rubbish from a room. The key practical question is whether an intervention improves a person’s health without creating other problems.

What do the dosing guides actually establish?

Unverified dosing proposals scale animal amounts and make assumptions about tissue effects. These are not clinical experiments, and the reported totals vary. Those calculations cannot establish a standard human regimen.

How would someone know it worked?

Feeling different after a course or seeing a biological-age score move does not demonstrate selective cell clearance or added healthy years. The useful outcomes would be sustained function and health, established in controlled human research. A relative timing curve cannot substitute for that evidence.

Model details: FOXO4-DRI · relative timing

Compare timing and buildup for this compound. The values are not blood concentrations or a measure of strength.

Shows a relative timing scenario; absolute blood concentrations are not calibrated.

Timing assumptions and sources

Legacy 12 h is not a human measured half-life. D-retro-inverso design or days between mouse doses do not quantify clearance.

One 1 mg input peaks at 1 relative unit after a single dose. Other amounts scale proportionally; overlapping doses add when accumulation is on. Different compounds use separate relative scales.

Timing half-life used
12 hours
Absorption half-life assumed
3 hours
Reference amount for the relative scale
1 mg
  • Absorption half-life is assumed to be one quarter of the slower timescale (3 h); it is not a measured absorption parameter.
  • A single 1-unit input has a peak of 1 relative unit; scaling and repeated-dose addition are mathematical assumptions. This normalization is independent of the example dose.
  • Mouse efficacy schedules are not human elimination evidence.
  • Different FOXO4 peptide sequences/conjugates cannot share calibration automatically.

foxo4-dri-relative-timing-2026-10 · version 1

Common questions

Does FOXO4-DRI reverse aging?

The original work showed effects in cells and mice. It does not establish reversal of aging, improved appearance or longer life in people.

Can mouse doses be scaled to make a human cycle?

Scaling is a research estimate, not a demonstration of a safe or effective regimen. It also cannot resolve route, tissue exposure and long-term effects.

Sources Labels, studies and notes behind this guide

Catalog evidence: Animal or laboratory research. This describes the type of evidence, not a clinical review of every claim.

Summary and fact source checks: 2026-10-07. This records source checking, not medical review of the whole page.

Notes on the quick facts

Main goal
Function and organ health matter more than an anti-aging label.
Senolytic meaning
It does not mean removing every old or damaged cell safely.
Human cycle
Online animal-to-human scaling is a hypothesis, not dose finding.
Related compounds and examples

Related compounds

Human Growth Hormone (HGH)

HGH is used medically to replace a diagnosed growth-hormone deficiency. Physique users seek fat loss, recovery and muscle fullness, but those goals differ from replacement treatment; swelling, hand symptoms and impaired glucose control can offset the hoped-for benefits.

CJC-1295 with DAC

CJC-1295 with DAC appeals to people seeking longer-lasting GH stimulation with fewer injections. Compare reported weekly use, trial doses, recovery goals and the trade-offs.

CJC-1295 without DAC (Modified GRF 1-29)

CJC-1295 no DAC is sought for better sleep, workout recovery and a leaner physique, often with ipamorelin. Compare reported doses, duration and the daily-use trade-off.

Comments

Loading comments…